Aflibercept is a medication used to treat certain types of eye conditions, such as age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR). It is a recombinant fusion protein that works by binding to and blocking Vascular Endothelial Growth Factor (VEGF), a protein involved in the development of abnormal blood vessels in the eye. By blocking VEGF, aflibercept decreases the growth of these abnormal blood vessels, thus helping to improve vision. It is typically injected into the eye every four to eight weeks, depending on the condition being treated.
Aflibercept, sold under the brand name Eylea, is a prescription medication used to treat various eye conditions that can lead to vision loss. Here's a detailed explanation:
What it treats:
- Aflibercept primarily targets conditions associated with abnormal blood vessel growth in the eye. These conditions include:
- Wet age-related macular degeneration (AMD): This is a progressive eye disease that affects the central vision, causing blurred vision, distortion, and difficulty seeing fine details.
- Diabetic macular edema (DME): This complication of diabetes occurs when fluid leaks from abnormal blood vessels in the macula, leading to distorted and blurred vision.
- Macular edema following retinal vein occlusion (RVO): Blockage of blood vessels in the retina can lead to fluid buildup and vision problems, which Aflibercept can help address.
- Diabetic retinopathy: In advanced stages, this diabetic complication can involve abnormal blood vessel growth that Aflibercept can help manage.
- Retinopathy of prematurity (ROP): This condition affects premature infants and involves abnormal blood vessel development in the retina. Aflibercept is used in severe cases to prevent vision loss.
How it works:
- Aflibercept belongs to a class of drugs called vascular endothelial growth factor (VEGF) inhibitors.
- VEGF is a protein that plays a crucial role in promoting the growth of new blood vessels, including abnormal ones.
- Aflibercept works by binding to and blocking the activity of VEGF, thereby inhibiting the formation of new blood vessels and reducing leakage from existing ones.
Dosage and administration:
- Aflibercept is administered as an injection directly into the affected eye by a qualified healthcare professional.
- The dosing frequency depends on the specific condition being treated and the patient's response to the medication.
- It is crucial to follow the exact dosing schedule prescribed by your doctor and to not miss or delay any injections.
Potential side effects:
- As with any medication, Aflibercept can cause side effects, although not everyone experiences them. Some potential side effects include:
- Eye pain, redness, or irritation
- Floaters (seeing spots or cobwebs in the vision)
- Changes in vision, including blurred vision
- Bleeding in the eye (rare)
- Increased risk of infection
Important information:
- Aflibercept is a powerful medication and should only be used under the supervision of an ophthalmologist (eye doctor).
- It is crucial to disclose your medical history to your doctor before starting Aflibercept, particularly if you have any pre-existing eye conditions or other health problems.
- Pregnancy and breastfeeding are not recommended with Aflibercept due to potential risks to the developing baby or infant.
Remember:
- Aflibercept is a valuable tool for managing various eye conditions, but it is not a cure.
- Regular follow-up appointments with your ophthalmologist are essential to monitor your treatment progress and address any potential side effects.
- If you experience any concerning symptoms after receiving Aflibercept, consult your doctor immediately.